Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

被引：0
|
作者：
Peace, James H. [1 ]
Medeiros, Felipe A. [2 ]
Martin, Keith R. [3 ,4 ]
Vittitow, Jason L. [5 ]
Weinreb, Robert N. [2 ,6 ]
机构：
[1] United Med Res Inst, Inglewood, CA USA
[2] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA
[3] Addenbrookes Hosp, Eye Dept, Cambridge, England
[4] Cambridge NIHR Biomed Res Ctr, Cambridge, England
[5] Bausch Lomb, Clin Affairs, Bridgewater, NJ USA
[6] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3035
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Integrated Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies
    Kaufman, Paul L.
    Liebmann, Jeffrey M.
    Vittitow, Jason L.
    Weinreb, Robert N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [2] Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study
    Medeiros, Felipe A.
    Martin, Keith R.
    Peace, James
    Sforzolini, Baldo Scassellati
    Vittitow, Jason L.
    Weinreb, Robert N.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 168 : 250 - 259
  • [3] Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension The APOLLO Study
    Weinreb, Robert N.
    Sforzolini, Baldo Scassellati
    Vittitow, Jason
    Liebmann, Jeffrey
    OPHTHALMOLOGY, 2016, 123 (05) : 965 - 973
  • [4] Long-term Efficacy and Safety of Latanoprostene Bunod 0.024% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: APOLLO and LUNAR Studies
    Vittitow, Jason L.
    Liebmann, Jeffrey M.
    Kaufman, Paul L.
    Medeiros, Felipe A.
    Martin, Keith R.
    Weinreb, Robert N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [5] Long-term Safety and Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: the JUPITER Study
    Kawase, Kazuhide
    Vittitow, Jason L.
    Yamamoto, Tetsuya
    Araie, Makoto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [6] Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
    Hoy, Sheridan M.
    DRUGS, 2018, 78 (07) : 773 - 780
  • [7] Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours
    Liu, John H. K.
    Slight, John R.
    Vittitow, Jason L.
    Sforzolini, Baldo Scassellati
    Weinreb, Robert N.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 169 : 249 - 257
  • [8] Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
    Sheridan M. Hoy
    Drugs, 2018, 78 : 773 - 780
  • [9] Latanoprostene Bunod 0.024% in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Meta-Analysis
    Lo, Tzu-Chen
    Chen, Yu-Yen
    Hung, Man-Chen
    Chou, Pesus
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [10] Response symmetry of the eyes to latanoprostene bunod (LBN) 0.024% in open-angle glaucoma and ocular hypertension
    Doustkhahvajari, Mahta
    Najafi, Ahmad
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
12345